Evidence map›Paper›PMID 23806096›Full record

Trial reportCardiovascular diabetology2013

Vitamin C further improves the protective effect of GLP-1 on the ischemia-reperfusion-like effect induced by hyperglycemia post-hypoglycemia in type 1 diabetes.

Antonio Ceriello, Anna Novials, Emilio Ortega, Silvia Canivell, Gemma Pujadas, Lucia La Sala, Loredana Bucciarelli, Maurizio Rondinelli, Stefano Genovese

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cardiovascular diabetology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06790771 (Acute Effect of Supplement Containing L-Arginine on Appetite Suppression and GLP-1 Induction), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06790771 nacompletednot on this mapstarted 2025, after this paper: background citation

Acute Effect of Supplement Containing L-Arginine on Appetite Suppression and GLP-1 Induction

TypeinterventionalSponsorTexas Christian UniversityRan2025 to 2026Enrolled25ConditionsHungerArmsHigh Dose Supplement, Low Dose Supplement, Placebo
3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Glucose Variability: How Does It Work?International journal of molecular sciences · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Antonio Ceriello
Anna Novials
Emilio Ortega
Silvia Canivell
Gemma Pujadas
Lucia La Sala
Loredana Bucciarelli
Maurizio Rondinelli
Stefano Genovese

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt has been reported that hyperglycemia following hypoglycemia produces an ischemia-reperfusion-like effect in type 1 diabetes. In this study the possibility that GLP-1 has a protective effect on this phenomenon has been tested.

methods15 type 1 diabetic patients underwent to five experiments: a period of two hours of hypoglycemia followed by two hours of normo-glycemia or hyperglycemia with the concomitant infusion of GLP-1 or vitamin C or both. At baseline, after 2 and 4 hours, glycemia, plasma nitrotyrosine, plasma 8-iso prostaglandin F2alpha, sCAM-1a, IL-6 and flow mediated vasodilation were measured.

resultsAfter 2 h of hypoglycemia, flow mediated vasodilation significantly decreased, while sICAM-1, 8-iso-PGF2a, nitrotyrosine and IL-6 significantly increased. While recovering with normoglycemia was accompanied by a significant improvement of endothelial dysfunction, oxidative stress and inflammation, a period of hyperglycemia after hypoglycemia worsens all these parameters. These effects were counterbalanced by GLP-1 and better by vitamin C, while the simultaneous infusion of both almost completely abolished the effect of hyperglycemia post hypoglycemia.

conclusionsThis study shows that GLP-1 infusion, during induced hyperglycemia post hypoglycemia, reduces the generation of oxidative stress and inflammation, improving the endothelial dysfunction, in type 1 diabetes. Furthermore, the data support that vitamin C and GLP-1 may have an additive protective effect in such condition.

Indexed as

AdultAntioxidantsAscorbic AcidBiomarkersBlood GlucoseDiabetes Mellitus, Type 1DinoprostFemaleGlucagon-Like Peptide 1HumansHyperglycemiaHypoglycemiaHypoglycemic AgentsInflammationInflammation MediatorsInfusions, Parenteral3-nitrotyrosine8-epi-prostaglandin F2alphaAntioxidantsAscorbic AcidBiomarkersBlood GlucoseDinoprostGlucagon-Like Peptide 1Hypoglycemic AgentsICAM1 protein, humanIL6 protein, humanInflammation MediatorsIntercellular Adhesion Molecule-1Interleukin-6Tyrosine

Identifiers

PMID23806096
PMCPMC3699412

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.